AI-Powered Drug Discovery
& RNA Therapeutics
Our innovative solution is based on an integrated approach leveraging artificial intelligence and conventional drug screening to bring new drugs to the rare disease market.
OUR APPROACH
At CERNAIS, we're breaking new
ground in drug discovery through our proprietary AI-powered approach.
By modulating the expression of X-linked genes we aim to restore cellular function and alleviate symptoms associated with Rett Syndrome, CDKL5 Deficiency Disorder and other diseases. We also offer fully personalised unbiased custom and repurposing screening services.
OUR APPROACH
At CERNAIS, we're breaking new
ground in drug discovery through our proprietary AI-powered approach.
By modulating the expression of X-linked genes we aim to restore cellular function and alleviate symptoms associated with Rett Syndrome, CDKL5 Deficiency Disorder and other diseases. We also offer fully personalised unbiased custom and repurposing screening services.
our team
Meet the dedicated team behind CERNAIS
Andrea Cerase
Drug-discovery & RNA biology
Jonathan Fiorentino
Machine Learning Bioinformatics
Gian Gaetano Tartaglia
Computational RNA biology Neural network Bioinformatics
